77 Ill. Adm. Code 2080.230
Designated Controlled Substances and Other Selected Drugs
Section 2080.230 Designated Controlled Substances and
Other Selected Drugs
For tracking purposes, the Department, upon recommendation
of the PMPAC, may designate and list drugs, other substances, and immediate
precursors as:
a) A Schedule I if the
Department finds that:
1)
the
substance has high potential for abuse; and
2)
the
substance has no currently accepted medical use in treatment in the United
States or lacks accepted safety for use in treatment under medical supervision
[720
ILCS 570/203].
b) A Schedule II if the
Department finds that:
1)
the
substance has high potential for abuse;
2)
the
substance has currently accepted medical use in treatment in the United States,
or currently accepted medical use with severe restrictions; and
3)
the
abuse of the substance may lead to severe psychological or physiological
dependence
[720 ILCS 570/205]
.
c) A Schedule III if the
Department finds that:
1)
the
substance has a potential for abuse less than the substances listed in
Schedules I and II;
2)
the
substance has currently accepted medical use in treatment in the United States;
and
3)
abuse
of the substance may lead to moderate or low physiological dependence or high
psychological dependence
[720 ILCS 570/207]
.
d) A Schedule IV if the
Department finds that:
1)
the
substance has a low potential for abuse relative to substances in Schedule III;
2)
the
substance has currently accepted medical use in treatment in the United States;
and
3)
abuse
of the substance may lead to limited physiological dependence or psychological
dependence relative to the substances in Schedule III
[720 ILCS 570/209]
.
e) A Schedule V if the
Department finds that:
1)
the
substance has low potential for abuse relative to the controlled substances
listed in Schedule IV;
2)
the
substance has currently accepted medical use in treatment in the United States;
and
3)
abuse
of the substance may lead to limited physiological dependence or psychological
dependence relative to the substances in Schedule IV, or the substance is a
targeted methamphetamine precursor as defined in the Methamphetamine Precursor
Control Act
[720 ILCS 648]. [720 ILCS 570/211]
f) Other Selected Drugs,
including:
1) those
medications that may contribute to clinical reviews of scheduled medications;
2) those
medications determined to need additional monitoring or to assist in
facilitating medication optimization and utilization; and
3) the dispensing of
Naloxone for opioid overdose prevention.